Detalhe da pesquisa
1.
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
N Engl J Med
; 388(7): 609-620, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791161
2.
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
J Infect Dis
; 229(1): 19-29, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433021
3.
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
J Virol
; 97(11): e0077123, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902399
4.
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-dose Influenza Vaccine in Adults 65 Years and Older: a Noninferiority Trial.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134393
5.
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
J Infect Dis
; 226(3): 396-406, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400792
6.
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
J Infect Dis
; 223(4): 699-708, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851411
7.
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years.
J Infect Dis
; 222(6): 979-988, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320465
8.
Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
N Engl J Med
; 371(8): 723-32, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25140958
9.
Pharmacokinetic interaction between telaprevir and methadone.
Antimicrob Agents Chemother
; 57(5): 2304-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478952
10.
Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores.
J Patient Rep Outcomes
; 7(1): 51, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261682
11.
Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers.
Intervirology
; 53(3): 176-82, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197684
12.
Resistance profile of darunavir: combined 24-week results from the POWER trials.
AIDS Res Hum Retroviruses
; 24(3): 379-88, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18327986
13.
Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers.
J Clin Pharmacol
; 48(1): 60-5, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094220
14.
The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers.
J Clin Pharmacol
; 47(4): 479-84, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17389557
15.
Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers.
Drugs R D
; 8(4): 241-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17596110
16.
Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.
Clin Pharmacol Drug Dev
; 3(5): 346-52, 2014 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27129006
17.
Pharmacokinetics of multiple-dose darunavir in combination with low-dose ritonavir in individuals with mild-to-moderate hepatic impairment.
Clin Pharmacokinet
; 49(5): 343-50, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20384396
18.
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients.
AIDS
; 23(14): 1829-40, 2009 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19474650
19.
Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Antimicrob Agents Chemother
; 51(3): 958-61, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17210768
20.
Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
J Acquir Immune Defic Syndr
; 49(5): 563-4, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19202459